Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study Finds

Rumored Trump VP Contender JD Vance Defends Him At Hush Money Trial—Here’s Who Else Is On Trump’s Likely VP Shortlist

Michael Cohen Testifying Today: How He Went From Lawyer Who’d ‘Take A Bullet’ For Trump To Prosecutors’ Key WitnessNovo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could slash the risk of heart attacks and strokes whether patients lose weight when taking it or not, according to new research, a finding that bolsters thePatients taking semaglutide had a 20% lower risk of heart attack, stroke or death due to cardiovascular...

University College London’s professor John Deanfield, who led the study, said the “findings have important clinical implications” and suggests semaglutide has another mechanism to lower cardiovascular risk other than reducing unhealthy body fat, adding that many more patients than are taking it now would likely benefit from the drug.

Technology Technology Latest News, Technology Technology Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive’ U.S. Drug PricesRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Source: Forbes - 🏆 394. / 53 Read more »

President Biden’s Latest Attack On The Economy: Smother The InternetSteve Forbes is Chairman and Editor-in-Chief of Forbes Media.
Source: ForbesTech - 🏆 318. / 59 Read more »